Search Within

Ronald A Ghossein

  1. "Survivorship Research"
Formats
  1. Journal Article (119)
  2. Meeting Abstract (57)
  3. Editorial (2)
  4. Conference Paper (1)
  5. Correspondence (1)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Department of Pathology and Laboratory Medicine (182)
  2. Survivorship Research (182)
  3. Surgery (151)
  4. Department of Medicine (137)
  5. Division of Subspecialty Medicine (128)
  6. Endocrinology (127)

More Groups

People
  1. Robert Tuttle (127)
  2. Ian Ganly (75)
  3. Snehal Patel (61)
  4. Ashok Shaha (60)
  5. Bin Xu (48)
  6. Jatin Shah (44)

More People

Years
  1. 2025 (3)
  2. 2024 (8)
  3. 2023 (6)
  4. 2022 (16)
  5. 2021 (8)
  6. 2020 (8)

More Years

Publications
  1. Thyroid (29)
  2. Modern Pathology (23)
  3. Laboratory Investigation (19)
  4. Annals of Surgical Oncology (10)
  5. Journal of Clinical Oncology (10)
  6. Cancer (9)

More Publications

Publishers
  1. Mary Ann Liebert, Inc (29)
  2. Nature Research (23)
  3. Nature Publishing Group (21)
  4. Elsevier Inc. (19)
  5. Springer (17)
  6. Wiley Blackwell (15)

More Publishers

Results (182)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinicopathologic and prognostic features of pediatric follicular cell-derived thyroid carcinomas: A retrospective study of 222 patients
    Journal Article

    Saliba, M.; Alzumaili, B. A.; Katabi, N.; Dogan, S.; Tuttle, R. M.; Zoltan, A.; Pandit-Taskar, N.; Xu, B.; Ghossein, R. A.
    American Journal of Surgical Pathology (2022)

    Fulltext@MSK | Save
  • Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis
    Journal Article

    Xu, B.; Saliba, M.; Alzumaili, B.; Alghamdi, M.; Lee, N.; Riaz, N.; Patel, S. G.; Ganly, I.; Dogan, S.; Ghossein, R. A.; more...
    Modern Pathology (2022)

    Fulltext@MSK | Save
  • Tumor grade predicts for calcitonin doubling times and disease-specific outcomes after resection of medullary thyroid carcinoma
    Journal Article

    Nigam, A.; Xu, B.; Spanheimer, P. M.; Ganly, I.; Tuttle, R. M.; Wong, R. J.; Shaha, A. R.; Ghossein, R. A.; Untch, B. R.
    Thyroid (2022)

    Fulltext@MSK | Save
  • Active surveillance of papillary thyroid cancer: Frequency and time course of the six most common tumor volume kinetic patterns
    Journal Article

    Tuttle, R. M.; Fagin, J.; Minkowitz, G.; Wong, R.; Roman, B.; Patel, S.; Untch, B.; Ganly, I.; Shaha, A.; Shah, J.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Use of intraoperative frozen section to assess final tumor margin status in patients undergoing surgery for oral cavity squamous cell carcinoma
    Journal Article

    Long, S. M.; Mclean, T.; Valero Mayor, C.; Fitzgerald, C. W. R.; Feit, N. Z.; Katabi, N.; Xu, B.; Cohen, M. A.; Ganly, I.; Ghossein, R. A.; more...
    JAMA Otolaryngology - Head and Neck Surgery (2022)

    Fulltext@MSK | Save
  • The solid variant of papillary thyroid carcinoma: A multi-institutional retrospective study
    Journal Article

    Xu, B.; Viswanathan, K.; Zhang, L.; Edmund, L. N.; Ganly, O.; Tuttle, R. M.; Lubin, D.; Ghossein, R. A.
    Histopathology (2022)

    Fulltext@MSK | Save
  • A pilot study of durvalumab (MEDI4736) with tremelimumab in combination with image-guided stereotactic body radiotherapy in the treatment of metastatic anaplastic thyroid cancer
    Journal Article

    Lee, N. Y.; Riaz, N.; Wu, V.; Brinkman, T.; Tsai, C. J.; Zhi, W.; Fetten, J.; Ho, A.; Wong, R. J.; Ghossein, R.; more...
    Thyroid (2022)

    Fulltext@MSK | Save
  • Tumor grade predicts calcitonin doubling times after curative resection of medullary thyroid cancer
    Meeting Abstract

    Nigam, A.; Xu, B.; Spanheimer, P. M.; Ganly, I.; Tuttle, R. M.; Wong, R. J.; Shaha, A. R.; Ghossein, R. A.; Untch, B. R.
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment
    Guidelines

    Shonka, D. C. Jr; Ho, A.; Chintakuntlawar, A. V.; Geiger, J. L.; Park, J. C.; Seetharamu, N.; Jasim, S.; Abdelhamid Ahmed, A. H.; Bible, K. C.; Brose, M. S.; more...
    Head & Neck (2022)

    Fulltext@MSK | Save
  • Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the anti-ERBB3 monoclonal antibody CDX-3379: Results of a pilot clinical trial
    Journal Article

    Tchekmedyian, V.; Dunn, L.; Sherman, E.; Baxi, S. S.; Grewal, R. K.; Larson, S. M.; Pentlow, K. S.; Haque, S.; Tuttle, R. M.; Sabra, M. M.; more...
    Thyroid (2022)

    Fulltext@MSK | Save